BMS-794833,
1174046-72-0,
BMS 794833,
BMS794833,
CHEMBL2143592,
3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-5-(4-fluorophenyl)-1,4-dihydro-4-oxo-,
N-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide,
N-{4-[(2-Amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl}-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide,
MLS006010952,
C23H15ClF2N4O3,
SCHEMBL700499,
SCHEMBL13770016,
DTXSID30657662,
EX-A550,
BCPP000323,
HMS3655B10,
KS-00001CS4,
BDBM50146164,
MFCD18206786,
ZINC43206812,
AKOS026750476,
BCP9000437,
CS-3982,
SB16591,
NCGC00263176-01,
NCGC00263176-03,
AK232460,
BC659940,
HY-10497,
QC-11785,
SMR004702756,
S2201,
SW220169-1,
X7501,
Z-3288,
J-690045,
J-690046,
BMS794833;1174046-72-0,
N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-5-(4-fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxamide,
N-{4-[(2-amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl}-5-(4-fluorophenyl)-4-oxo-1H-pyridine-3-carboxamide,
Brigatinib,
cc-603,
PDYXPCKITKHFOZ-UHFFFAOYSA-N,
B1438,
A10154,
3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-1,2-oxazole-4-carboxamide,